Tachycardia-related cardiomyopathy: A common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation

Mayo Clinic Proceedings

Volumn 75, Issue 8, 2000, Pages 790-795

  Redfield, Margaret M ^a   Neal Kay, G ^b   Jenkins, Louise S ^c   Mianulli, Marcus ^d   Nick Jensen, D ^d   Ellenbogen, Kenneth A ^e,p   Kay, G Neal ^f   Wells, Peter J ^g   Josephson, Mark ^h   Crossley, George ⁱ   Wilber, David ^j   Wilkoff, Bruce ^k   Natale, Andrea ^l   Curtis, Anne ^m   Giudici, Michael ⁿ   Kutalek, Steven ^o   Hammill, Stephen C ^a   Onufer, John R ^q   Prior, Michael ^r   DiMarco, John ^s  

^a MAYO CLINIC   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF NURSING   (United States)

^d MEDTRONIC INC   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g Baylor University Heart Place ^*  (United States)

^h BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

ⁱ WAKE FOREST SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF CHICAGO   (United States)

^k LERNER RESEARCH INSTITUTE   (United States)

^l DURHAM VA MEDICAL CENTER   (United States)

^m UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

ⁿ Genesis Medical Center   (United States)

^o DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^p HUNTER HOLMES MCGUIRE VA MEDICAL CENTER   (United States)

^q SENTARA NORFOLK GENERAL HOSPITAL   (United States)

^r TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^s UNIVERSITY OF VIRGINIA MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CATHETER ABLATION; CLINICAL TRIAL; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART PACING; HUMAN; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT REFERRAL; TACHYCARDIA;

EID: 0033874293     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/75.8.790     Document Type: Article

References (29)

1. Yamamoto K, Burnett JC Jr, Meyer LM, Sinclair L, Stevens TL, Redfield MM. Ventricular remodeling during development and recovery from modified tachycardia-induced cardiomyopathy model. Am J Physiol. 1996;271 :R 1529-R1534.
2. Tomita M, Spinale FG. Crawford FA, Zile MR. Changes in left ventricular volume, mass, and function during the development and regression of supraventricular tachycardia-induced cardiomyopathy: disparity between recovery of systolic versus diastolic function. Circulation. 1991;83:635-644.
3. Eble DM, Spinale FG. Contractile and cytoskeletal content, structure, and mRNA levels with tachycardia-induced cardiomyopathy. Am J Physiol. 1995;268:H2426-H2439.
4. Shinbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Scheinman MM. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol. 1997;29:709-715.
5. Fenelon G, Wijns W, Andries E, Brugada P. Tachycardiomyopathy: mechanisms and clinical implications. Pacing C/in Electrophysio!. 1996:19:95-106.
6. Grogan M, Smith HC, Gersh BJ, Wood DL. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol. 1992;69: 1570-1573.
7. Phillips E, Levine SA. Auricular fibrillation without other evidence of heart disease: a cause of reversible heart failure. Am J Med. 1949:7:478-489.
8. Kasper EK, Agema WRP, Hutchins GM, Deckers JW, Hare JM, Baughman KL. The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. J Am Coll Cardiol. 1994:23:586-590.
9. Kay GN, Ellenbogen KA, Giudici M, et al. The Ablate and Pace Trial : a prospective study of catheter ablation of the A V conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. J Interventional Cardiac Electrophysiol. 1998;2: 121-135.
10. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58: 1072-1083.
11. Schiller NB, Shah PM, Crawford M, et al, American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 1989:2:358-367.
12. Nishimura RA, Miller FA Jr, Callahan MJ, Benassi RC, Seward JB, Tajik AJ. Doppier echocardiography: theory, instrumentation, technique, and application. Mayo Clin Proc. 1985:60:321-343.
13. QuinonesMA, Waggoner AD, Reduto LA, et al. Anew, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation. 1981;64:744-753.
14. Michels VV, Moll PP, Miller FA, et al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med. 1992:326:77-82.
15. Twidale N, McDonald T, Nave K, Seal A. Comparison of the effects of AV nodal ablation versus AV nodal modification in patients with congestive heart failure and uncontrolled atrial fibrillation. Pacing Clin Electrophysiol. 1998;21:641 -651.
16. Morady F, Hasse C, Strickberger SA, et al. Long-term follow-up after radiofrequency modification of the atrioventricular node in patients with atrial fibrillation. J Am Coll Cordial. 1997:29:113121.
17. Rodriguez LM, Smeets JL, Xie B, et al. Improvement in left ventricular function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation. Am J Cardiol. 1993; 72:1137-1141.
18. Geelen P, Goethals M, de Bruyne B, Brugada P. A prospective hemodynamic evaluation of patients with chronic atrial fibrillation undergoing radiofrequency catheter ablation of the atrioventricular junction. Am J Cardiol. 1997;80:1606-1609.
19. Luchsinger JA, Steinberg JS. Resolution of cardiomyopathy after ablation of atrial flutter. J Am Coll Cardiol. 1998;32:205-210.
20. Brown CS, Mills RM Jr, Conti JB, Curtis AB. Clinical improvement after atrioventricular nodal ablation for atrial fibrillation does not correlate with improved ejection fraction. Am J Cardiol. 1997;80:1090-1091.
21. Edner M, Caidahl K, Bergfeldt L, Darpo B, Edvardsson N, Rosenqvist M. Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation. Br Heart J. 1995:74:261-267.
22. Twidale N, Sutton K, Bartlett L, et al. Effects on cardiac performance of atrioventricular node catheter ablation using radiofrequency current for drug-refractory atrial arrhythmias. Pacing Clin Electrophysiol. 1993; 16:1275-1284.
23. Van Gelder IC, Crijns HJ, Blanksma PK, et al. Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. Am] Cardiol. 1993;72:560-566.
24. Heinz G, Siostrzonek P, Kreiner G, Gossinger H. Improvement in left ventricular systolic function after successful radiofrequency His bundle ablation for drug refractory, chronic atrial fibrillation and recurrent atrial flutter. Am J Cardiol. 1992;69:489-492.
25. Brignole M, Gianfranchi L, Menozzi C, et al. Influence of atrioventricular junction radiofrequency ablation in patients with chronic atrial fibrillation and flutter on quality of life and cardiac performance. Am J Cardiol. 1994;74:242-246.
26. Lee SH, Chen SA, Tai CT, et al. Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation. J Am Coll Cardiol. 1998; 31:637-644.
27. Stevens TL, Borgeson DD, Luchner A, Wennberg P, Redfield MM, Burnett JC Jr. A modified model of tachycardia-induced cardiomyopathy: insights into humoral and renal adaptations. In: Spinale FG, ed. Pathophysiology of Tachycardia-Induced Heart Failure. Armonk, NY: Futura Publishing Co; 1996:133-151.
28. Clark DM, Plumb VJ, Epstein AE, Kay GN. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol. 1997;30:1039-1045.
29. Sarter BH. Marchlinski FE. Redefining the role of digoxin in the treatment of atrial fibrillation. Am J Cardiol. 1992;69:71G-81G.